ChemicalBook > CAS DataBase List > Ropsacitinib

Ropsacitinib

Product Name
Ropsacitinib
CAS No.
2127109-84-4
Chemical Name
Ropsacitinib
Synonyms
Tyk2-IN-8;PF6826647;PF 6826647;PF-6826647;PF-06826647;Ropsacitinib;PF-06826647( Tyk2-IN-8);Ropsacitinib (PF-06826647;Cyclobutaneacetonitrile, 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]-, trans-;cis-3-(Cyanomethyl)-3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}cyclobutanecarbonitrile
CBNumber
CB04923831
Molecular Formula
C20H17N9
Formula Weight
383.41
MOL File
2127109-84-4.mol
More
Less

Ropsacitinib Property

Density 
1.46±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO: 16.67 mg/mL (43.48 mM)
pka
0.98±0.19(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H312Harmful in contact with skin

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0101462
Product name
PF-06826647
Purity
99.82%
Packaging
5mg
Price
$550
Updated
2021/12/16
ChemScene
Product number
CS-0101462
Product name
PF-06826647
Purity
99.82%
Packaging
10mg
Price
$990
Updated
2021/12/16
ChemScene
Product number
CS-0101462
Product name
PF-06826647
Purity
99.82%
Packaging
50mg
Price
$2550
Updated
2021/12/16
Crysdot
Product number
CD31005026
Product name
PF-06826647
Purity
98%
Packaging
5mg
Price
$790
Updated
2021/12/16
More
Less

Ropsacitinib Chemical Properties,Usage,Production

Uses

trans-3-Cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]cyclobutaneacetonitrile is a selective inhibitor of Tyrosine Kinase 2 (TYK2).

Biological Activity

The discovery of ropsacitinib, a dual JAK1/TYK2 inhibitor, was guided by previous research and molecular modeling on brepocitinib that revealed distinct hinge binding to the main chain atoms of Val981. ropsacitinib exhibited high JAK1 and JAK3 selectivity (>160-fold) and  modest JAK2 selectivity (12-fold).

Pharmacokinetics

Ropsacitinib is neutral at physiological pH with a pKa of < 1.7. The crystalline material showed very poor thermodynamic solubility (0.3 μg/mL at pH 7.4), and the lack of a basic group precluded salt formation to improve solubility. The solubility issue was mitigated through a spray-dried dispersion (SDD) formulation, which increased experimental intestinal solubility to approximately 160?180 μM (60?70 μg/mL). Ropsacitinib displayed high passive membrane permeability in MDCK-LE cells (mean Papp = 16.7 × 10?6 cm/s) but is a substrate for MDR1 (efflux ratio > 6) and BCRP (efflux ratio > 2) efflux transport. Following oral administration of the crystalline (non SDD) material to rats at 3 and 30 mpk, ropsacitinib showed an oral bioavailability of 15% and 8% respectively. The SDD formulation increased oral bioavailability to 58% and 63% at 3 and 30 mpk, respectively. The oral bioavailability in humans was expected to be dose-dependent due to poor solubility. In healthy volunteers, the terminal elimination half-life of ropsacitinib in a single ascending dose (SAD) study is also dose-dependent: for example, approximately 6 hours at 10 mg dose and 15 hours at 400 mg dose. Ropsacitinib underwent hepatic clearance in humans primarily through the CYP450-mediated (via CYP1A2, CYP2D6, and CYP3A) metabolism, resulting in N-demethylation of the pyrazole (6), hydroxylation of the pyrazole (5), and addition of oxygen (e.g., 4) and loss of the nitrile group (e.g., 7).

Ropsacitinib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Ropsacitinib Suppliers

Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
18088
Advantage
64
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9449
Advantage
58
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3423
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4153
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9709
Advantage
58
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Shanghai Rechem science Co., Ltd.
Tel
21-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2995
Advantage
58
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 4009686088
Email
3193328036@qq.com
Country
China
ProdList
29796
Advantage
68
Kaixin Chemical (Hong Kong) Limited
Tel
010-88886666-01 13112345678
Fax
CDXH21@126.com
Email
loyson@tcypharm.com
Country
China
ProdList
595
Advantage
55
Shanghai Scochem Technology Co., Ltd.
Tel
021-33758897
Email
sales@scochem.com
Country
China
ProdList
1598
Advantage
58
NINGBOBENKANGJS PHARMTECHCO., LTD
Tel
+8615990591583 15990591583
Country
CHINA
ProdList
2029
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
sales@dcchemicals.com
Country
China
ProdList
9414
Advantage
58
Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd.
Tel
15990591583
Fax
qq: 1050376806 mailbox : sales@nbpharmabridge.com
Country
China
ProdList
5561
Advantage
58
Shanghai Subo Pharmaceutical Technology Co., Ltd.
Tel
021-54156369 16621315851
Email
yhsuyiming@126.com
Country
China
ProdList
306
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11289
Advantage
58
Taizhou Nanfeng Pharmaceutical Research Institute
Tel
12345678910
Fax
nanfengdrug@163
Email
nanfengdrug@163.com
Country
China
ProdList
15323
Advantage
58
Wuhan Topule
Tel
+86-02787215551 +86-19945035818
Fax
027-87215551
Email
2936752263@qq.com
Country
China
ProdList
7955
Advantage
58
Beijing Hanlun Science and Technology Development Co., Ltd.
Tel
010-67713695 13810760018
Fax
010-87743061
Email
2850327064@qq.com
Country
China
ProdList
646
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7974
Advantage
58
Wuhan Augda Biotechnology Co., Ltd
Tel
15071299552
Fax
QQ:262933239
Email
262933239@qq.com
Country
China
ProdList
6637
Advantage
58
Jinan Billion Pharmaceutical Technology Co., Ltd
Tel
+86-15589952515 +86-15589952515
Email
80912934@qq.com
Country
China
ProdList
56
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 15221909166
Email
product02@bidepharm.com
Country
China
ProdList
63720
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6713
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
+86-027-59232304 15387063101
Email
2881924050@qq.com
Country
China
ProdList
9892
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24018
Advantage
58
WEITIXIHAUGONG
Tel
0371-53370800 18037197114
Email
2853031799@qq.com
Country
China
ProdList
10009
Advantage
58
Wuhan Yuxiang Medical Technology Co., Ltd.
Tel
13971275651
Email
sales@whyxpharma.com
Country
China
ProdList
3784
Advantage
58
Xianning Shen Lan Biomedical Research and Development Co., Ltd.
Tel
18171815831
Email
1341138380@qq.com
Country
China
ProdList
2780
Advantage
58
Shanghai Tachizaki Biomedical Research Center
Tel
18014399201
Email
sales@chemlab-tachizaki.com
Country
China
ProdList
2491
Advantage
58
Nantong QuanYi Biotechnology Co., Ltd
Tel
0513-66337626 18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
4191
Advantage
58
Jinan zhongdaoanran chemical Co;Ltd
Tel
18678233466 18678233466
Email
122574856@qq.com
Country
China
ProdList
102
Advantage
58
https://www.shachemlin.cn/
Tel
021-68080707 15021879576
Email
wen-jing.ma@chemlin.com.cn
Country
China
ProdList
9859
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 18112977050
Email
cb5@aikonchem.com
Country
China
ProdList
10529
Advantage
58
Wuhan Acumen Bio-Technology Co.,ltd
Tel
027-027-16602739303 16602739303
Email
673003916@qq.com
Country
China
ProdList
2929
Advantage
58
Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.
Tel
13771642864
Fax
1078336263
Email
snhuyu_2008@126.com
Country
China
ProdList
1028
Advantage
58
Wuhan WinYuanBei Trading Company
Tel
86-13349903920; 13349903920
Fax
-
Email
869523959@qq.com
Country
China
ProdList
9415
Advantage
58
Shanghai jerryxing Biomedical Technology Co., Ltd
Tel
17721492509
Email
643638326@qq.com
Country
China
ProdList
5347
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525
Email
209533805@qq.com
Country
China
ProdList
9621
Advantage
58
LEAPCHEM CO., LTD.
Tel
+86-852-30606658
Email
market18@leapchem.com
Country
China
ProdList
43348
Advantage
58
Jinan Million Pharmaceutical Co., Ltd
Tel
+86-531-68659554 +8613031714605
Fax
Room1-2208, Gaoxin district, Jinan, Shandong
Email
info@millionpharm.com
Country
China
ProdList
159
Advantage
58
Wuhan Topule Biopharmaceutical Co., Ltd
Tel
+8618327326525
Email
masar@topule.com
Country
China
ProdList
8474
Advantage
58
Nantong HI-FUTURE Biology Co., Ltd.
Tel
+undefined18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
3136
Advantage
58
Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel
+86-057181025280; +8617767106207
Fax
0571-85806285
Email
sales@molcore.com
Country
China
ProdList
49739
Advantage
58
Shanghai Hao Zhun Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
info@zzsrm.com
Country
CHINA
ProdList
6846
Advantage
58
More
Less

View Lastest Price from Ropsacitinib manufacturers

Jinan Million Pharmaceutical Co., Ltd
Product
Ropsacitinib/PF-06826647 2127109-84-4
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
1200KG/M
Release date
2023-08-11

2127109-84-4, RopsacitinibRelated Search:


  • (1r,3r)-3-(cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutanecarbonitrile
  • PF-06826647
  • Tyk2-IN-8
  • Cyclobutaneacetonitrile, 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]-, trans-
  • PF-06826647( Tyk2-IN-8)
  • Ropsacitinib (PF-06826647
  • trans-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutanecarbonitrile
  • Ropsacitinib
  • cis-3-(Cyanomethyl)-3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}cyclobutanecarbonitrile
  • PF 6826647
  • PF6826647
  • PF-6826647
  • 2127109-84-4